Literature DB >> 11279792

Imaging multidrug resistance with radiolabeled substrates for P-glycoprotein and multidrug resistance protein.

J R Ballinger.   

Abstract

Mesh:

Substances:

Year:  2001        PMID: 11279792     DOI: 10.1089/108497801750095907

Source DB:  PubMed          Journal:  Cancer Biother Radiopharm        ISSN: 1084-9785            Impact factor:   3.099


× No keyword cloud information.
  5 in total

Review 1.  Nuclear imaging of molecular processes in cancer.

Authors:  Rafael Torres Martin de Rosales; Erik Arstad; Philip J Blower
Journal:  Target Oncol       Date:  2009-09-25       Impact factor: 4.493

2.  To use MIBI or not to use MIBI? That is the question when assessing tumour cells.

Authors:  Jean-Luc Moretti; Nathalie Hauet; Meltem Caglar; Olivier Rebillard; Zeynep Burak
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-07       Impact factor: 9.236

3.  In vitro detection of mdr1 mRNA in murine leukemia cells with 111In-labeled oligonucleotide.

Authors:  Jingming Bai; Kunihiko Yokoyama; Seigo Kinuya; Kazuhiro Shiba; Ryo Matsushita; Masaaki Nomura; Takatoshi Michigishi; Norihisa Tonami
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-09-21       Impact factor: 9.236

4.  Enhanced anti-tumor effects of combined MDR1 RNA interference and human sodium/iodide symporter (NIS) radioiodine gene therapy using an adenoviral system in a colon cancer model.

Authors:  S J Ahn; Y H Jeon; Y J Lee; Y L Lee; S-W Lee; B-C Ahn; J-H Ha; J Lee
Journal:  Cancer Gene Ther       Date:  2010-02-26       Impact factor: 5.987

5.  Reduction of 99mTc-sestamibi and 99mTc-tetrofosmin uptake in MRP-expressing breast cancer cells under hypoxic conditions is independent of MRP function.

Authors:  Seigo Kinuya; Xiao-Feng Li; Kunihiko Yokoyama; Hirofumi Mori; Kazuhiro Shiba; Naoto Watanabe; Noriyuki Shuke; Hisashi Bunko; Takatoshi Michigishi; Norihisa Tonami
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-07-31       Impact factor: 9.236

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.